Myeloperoxidase modulates the phagocytic activity of polymorphonuclear neutrophil leukocytes. Studies with cells from a myeloperoxidase-deficient patient.
Olle Stendahl(Linköping University), L Molin(Linköping University), Cláes Dahlgren(Centre for Inflammation Research), B.-I. Coble(Linköping University), J. Hed
Cited by 111
Related Papers
International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the Formyl Peptide Receptor (FPR) Family
|Pharmacological Reviews|2009|770
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
|British Journal of Pharmacology|2023|390
Mobilization of granules and secretory vesicles during in vivo exudation of human neutrophils.
|The Journal of Immunology|1995|314
Role of myeloperoxidase in luminol-dependent chemiluminescence of polymorphonuclear leukocytes
|Infection and Immunity|1983|244